A role for the Pkc1p/Mpk1p kinase cascade in the morphogenesis checkpoint

Author:  ["Jacob C. Harrison","Elaine S.G. Bardes","Yoshikazu Ohya","Daniel J. Lew"]

Publication:  Nature Cell Biology

CITE.CC academic search helps you expand the influence of your papers.

Tags:  general   CellBiology   CancerResearch   DevelopmentalBiology   StemCells   Biological

Abstract

In many cells the timing of entry into mitosis is controlled by the balance between the activity of inhibitory Wee1-related kinases (Swe1p in budding yeast) and the opposing effect of Cdc25-related phosphatases (Mih1p in budding yeast) that act on the cyclin-dependent kinase Cdc2 (Cdc28p in budding yeast)1. Wee1 and Cdc25 are key elements in the G2 arrest mediated by diverse checkpoint controls2. In budding yeast, a `morphogenesis checkpoint' that involves Swe1p and Mih1p delays mitotic activation of Cdc28p3. Many environmental stresses (such as shifts in temperature or osmolarity) provoke transient depolarization of the actin cytoskeleton, during which bud construction is delayed while cells adapt to environmental conditions. During this delay, the morphogenesis checkpoint halts the cell cycle in G2 phase until actin can repolarize and complete bud construction, thus preventing the generation of binucleate cells4. A similar G2 delay can be triggered by mutations or drugs that specifically impair actin organization5, indicating that it is probably actin disorganization itself, rather than specific environmental stresses, that triggers the delay. The G2 delay involves stabilization of Swe1p in response to various actin perturbations6, although this alone is insufficient to produce a long G2 delay7.

Cite this article

Harrison, J., Bardes, E., Ohya, Y. et al. A role for the Pkc1p/Mpk1p kinase cascade in the morphogenesis checkpoint . Nat Cell Biol 3, 417–420 (2001). https://doi.org/10.1038/35070104

View full text

>> Full Text:   A role for the Pkc1p/Mpk1p kinase cascade in the morphogenesis checkpoint

TGFβ influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b

Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-κB